{"id":269861,"date":"2026-07-12T12:40:12","date_gmt":"2026-07-12T12:40:12","guid":{"rendered":"https:\/\/www.europesays.com\/at\/269861\/"},"modified":"2026-07-12T12:40:12","modified_gmt":"2026-07-12T12:40:12","slug":"novo-nordisk-baut-pipeline-aus-novo-nordisk-aktie-neue-haemophiliedaten-staerken-portfolio-jenseits-von-wegovy-boersennews-de","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/at\/269861\/","title":{"rendered":"Novo Nordisk baut Pipeline aus: Novo Nordisk Aktie neue H\u00e4mophiliedaten st\u00e4rken Portfolio jenseits von Wegovy &#8211; B\u00f6rsenNEWS.de"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiigJBVV95cUxPNFp4M0NuRElUSGdsY05ldWNVMkhreVE3OUEzQUpBWWJHMUdfYVBvYXgyRFdjMnNqQWs3UkVzTXlXVFBfWU5ERzhyQVUzaFo1VnNIZzBtd2NFcktpRVRxNzYtM3A3OWlXbGZuQm00c0l4UnRRcGQ5cEdCazFQbVItbzJzZ1ZSeGVVNzVUY2NSY29mS2lERlR4ZWxmaE54RTFuN2FpQzZNVUVWZUQtemVFMFphZllrdWRRdzc2c09oVUROa09jVDdCQ1EwRS1HVFJhTEFiaHBkNTBtcWxHbGFBUjVGU29abm51WHZkZm4yRlQ3aDAwTng4NzdCQmVMVFlfZHotUDNYcEZkZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Novo Nordisk baut Pipeline aus: Novo Nordisk Aktie neue H\u00e4mophiliedaten st\u00e4rken Portfolio jenseits von Wegovy<\/a>&nbsp;&nbsp;B\u00f6rsenNEWS.de<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMirwFBVV95cUxPb3JGaHRHel9xU21panBBdUo3ZUprUm8yUWFHZzF3S29leVZhdGUxOGhSRF9qRUdtWTJfemxMNU5wVnNrSVVORmExandzSzZRWnFNMmN3VVNESi1xSUlZWGNuaGVhMlU1VzZfYmtUUWxQd2FyQy1oN0h3OGJfT0FpRGtfR1l1WlpjN19wUHd0MFpJa2lNX3JGYlA1V0NMVVBZbkViejZHeU5CX3UwYmx3?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Novo Nordisk-Aktie: Studienerfolg bei H\u00e4mophilie-Therapie<\/a>&nbsp;&nbsp;finanzen.at<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMipwFBVV95cUxQT1BzZEt1NVVPUGMyOGJhd3N4Q3E1Wm1wclJGT3hiZkFpUWRKWlZmS0NzUHJYVWdYYXloY1pTNmIzZVNpRENFMld4Nk9ycXhRU1phYUZLVXppZVk4RGt4dUlfRWJGOWhKMmE2a0VaaDF0a2d4bGl5b0x5dXZrVkdwR3BETFVMU1NKQy11MUtFT1N4b3NDVkxQWDJIemJTblljdEE3MHYyYw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Novo Nordisk Aktie: 17 Prozent Kursgewinn in 30 Tagen<\/a>&nbsp;&nbsp;B\u00f6rse Express<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMifEFVX3lxTE0wX2ZZQzFBVkJyaURhcXBHYnB4dzJScFAwS1NROUg5UUE5bjFudmNKcG95V3YzX3hIUkJRVU5ISXVNOWk5UFctZGY0elU3Vng2dVVlT1NVTW05UUtMOVVBeVlXei01d1BJTmEySk9yOGVlTkZyS2tsWk9EZ0rSAYIBQVVfeXFMTVZlbVlua0NxYklfMGI3MlNNMWdOU1pxaVlBakY2Q1JKdmtzaEdpeExOZXp0YWR1V0pxbC1ZLUljZm9CSXhNVkIyZEdZbGpQZlo5TEItUEo0NkpWaUo3a2JteEpvUFpkOXpnaktCWkpxc0NCS0Vha1h3NlZ0WW10ZXlEZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Novo Nordisk untermauert bei H\u00e4mophilie-Wirkstoff denecimig die klinischen Daten<\/a>&nbsp;&nbsp;4investors.de<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiigFBVV95cUxQRGxNTEdJQTUtazdMQlRPZ2phRTctUFp4WGd3WllMbDJKOVBwLUctSl96RHpRazFyeDFjVVRobEMwZlU2ZmYxeW5WdVh0TF9ZcVZkXzN1d28tUzZmZVVLQ0ZnRUVveDNnenBMSXVHY2hER2tpLWVMWWVVUHU0VjBaZmwtV3Nmc1lwZ1E?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Novo Nordisk Aktie: Fortschritt bei Bluterkrankheit<\/a>&nbsp;&nbsp;Trading-Treff<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk baut Pipeline aus: Novo Nordisk Aktie neue H\u00e4mophiliedaten st\u00e4rken Portfolio jenseits von Wegovy&nbsp;&nbsp;B\u00f6rsenNEWS.deNovo Nordisk-Aktie: Studienerfolg bei&hellip;\n","protected":false},"author":2,"featured_media":269862,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[46,42,72885,95,90,89,72884,91,94,72883,44,15889,93,92,13583],"class_list":["post-269861","post","type-post","status-publish","format-standard","has-post-thumbnail","category-unternehmen-maerkte","tag-at","tag-austria","tag-blutgerinnungsstoerungen","tag-business","tag-companies","tag-companies-markets","tag-haemophiliedaten","tag-markets","tag-maerkte","tag-novonordisk","tag-oesterreich","tag-pipeline","tag-unternehmen","tag-unternehmen-maerkte","tag-wegovy"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@at\/116907057108722494","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/269861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/comments?post=269861"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/269861\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media\/269862"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media?parent=269861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/categories?post=269861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/tags?post=269861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}